FBXW7 and breast carcinoma: Aberration or inactivation of FBW7 expression has been observed in human cancers, such as breast cancer [57], and leukemia [58], which is thought to be involved in tumorigenesis, progress, prognosis, and drug resistance [24, 59, 60].